Czechia· CZ-0238815

RECARBRIO

A imipenem, cilastatin and relebactam product containing imipenem monohydrate + cilastatin sodium + relebactam monohydrate, registered in Czechia by Merck Sharp & Dohme B.V., Haarlem. The same ATC class is registered in 11 of our 19 countries.

ATC J01DH56

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedRECARBRIOATCJ01DH56REGISTER NO.CZ-0238815PACKS LISTED0CHECKEDSeptember 28, 2026

Where it is registered

Imipenem, cilastatin and relebactam is registered in 11 of 19 countries.

Countries holding a registration under ATC J01DH56 (imipenem, cilastatin and relebactam), each read from that country’s own register.

  • This record: Czechia, from SÚKL (Czech Republic)
  • 7 of them publish a price we can compare per daily dose

Imipenem, cilastatin and relebactam · ATC J01DH56

11 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

SÚKL (Czech Republic)
Active substance
IMIPENEM MONOHYDRATE + CILASTATIN SODIUM + RELEBACTAM MONOHYDRATE
Manufacturer
Merck Sharp & Dohme B.V., Haarlem
Country
Czechia (CZ)
ATC code
J01DH56
ATC class
Imipenem, cilastatin and relebactam
Defined daily dose
2 g, P
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
September 28, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/110d1db6-75ab-4272-ac1b-f16629e862ae
GET /v1/drugs/110d1db6-75ab-4272-ac1b-f16629e862ae?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "INF PLV SOL",
  "source": "sukl",
  "strength": "500MG/500MG/250MG",
  "pack_size": "25",
  "substance": "IMIPENEM MONOHYDRATE + CILASTATIN SODIUM + RELEBACTAM MONOHYDRATE",
  "cz_kod_sukl": "0238815",
  "product_type": "CH",
  "substance_codes": "9667,9672,82",
  "registration_state": "R",
  "registration_number": "EU/1/19/1420/001"
}

See everything about imipenem, cilastatin and relebactam.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.